| Followers | 79 |
| Posts | 3015 |
| Boards Moderated | 0 |
| Alias Born | 12/04/2020 |
Sunday, January 31, 2021 7:57:57 PM
Glad to see someone gets it. The rise from the teens to .72 USD and consolidation for weeks in the mid .40 USD range has been all due to what I like to call the first wave of the shroom boom. Second wave is coming in late spring to early summer. RVV is going to $1.00 USD by June regardless of what happens with Bucillamine.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
